tm logo
KALVISTA
SEARCHED

on 12 Jan 2024

Last Applicant/ Owned by

KALVISTA PHARMACEUTICALS LIMITED

Porton Science Park, Bybrook Road,Porton DownSalisbury, Wiltshire SP4 0BF

GB

Serial Number

2213217 filed on 20th Jul 2022

Correspondent Address

(Dipchand LLP)401 Bay Street, Suite 2100Toronto

ONTARIO

CA

M5H2Y4

KALVISTA

Trademark usage description

pharmaceutical preparations for the treatment of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of diabetic macular Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of diabetic macular edema; pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders.


Classification kind code

11

Class [010]
Medical and surgical instruments and apparatus for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders; drug delivery devices for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders.


Classification kind code

11

Class [042]
Drug discovery services relating to ophthalmic diseases and disorders; drug discovery services relating to diabetic macular edema; drug discovery services relating to angioedema; drug discovery services relating to hereditary angioedema; drug discovery services relating to diseases and disorders mediated by the contact activation system; drug discovery services relating to plasma kallikrein or factor XIIa mediated diseases or disorders.


Classification kind code

11

Class [044]
Medical and healthcare services relating to ophthalmic diseases and disorders; medical and health care services relating to diabetic macular edema; medical and healthcare services relating to angioedema; medical and healthcare services relating to hereditary angioedema; medical and healthcare services relating to diseases and disorders mediated by the contact activation system; medical and healthcare services relating to plasma kallikrein or factor XIIa mediated diseases or disorders.


Classification kind code

11

Mark Details


Serial Number

2213217

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 12th Jan 2024
Search Recorded
Submitted for opposition 20
on 12th Jan 2024
Examiner's First Report
Submitted for opposition 256
on 31st Jul 2023
Notification of Possible Opposition Sent
Submitted for opposition 48
on 12th Apr 2023
Agent Changed
Submitted for opposition 48
on 17th Jan 2023
Agent Changed
Submitted for opposition 31
on 01st Oct 2022
Formalized
Submitted for opposition 1
on 01st Oct 2022
Created
Submitted for opposition 257
on 29th Sep 2022
Designation Notification - Madrid Protocol
Submitted for opposition 228
on 20th Jul 2022
International Registration
Submitted for opposition 30
on 20th Jul 2022
Filed